July 7 - Members and Subscribers - Welcome to the new and improved abi.org! - If you have not already done so, please reset your ABI password to access the site. Click "Login" and then "Forgot Password"
Insys Therapeutics, a drug company that produced and marketed a fentanyl-based painkiller, filed for chapter 11 protection in Delaware on June 10, 2019.[1] It is the first bankruptcy case of the opioid era, and it will not be the last.[2]
It is well established that health care businesses are confronted with significant financial challenges, including lower reimbursement rates, constant changes in the delivery of services, increased competition and the need for expensive capital improvements to adopt the latest technology. Recent political uncertainty and heightened government scrutiny has only exacerbated these challenges.
